58% of all sites have lines impacted by FMD
(Falsified Medicines Directive) or DSCSA
(Drug Supply Chain Security Act)
All have one line impacted, 10% have more than 15
Nearly half the lines (48%) are yet to be ‘Serialisation Ready’
The majority of packaging consists of Blister packs
and Vials (a few focus on syringes)
For the lines impacted by legislation, 75% see app, half the products are placed in a carton, and for most (69%), at least 10% are placed in cartons.
This means that 57% are in cartons
For many (21%) for at least 75% of the impacted lines the product is bundled and for over half, at least some of the product is bundled
66% of the lines that are not ‘Serialisation Ready’ no action is planned for the next 12 months!
69% will be looking for a standard serialisation approach across all lines
60% of responders will acquire their Serialisation Printer direct from the printer manufacturer, another 26% will get theirs from a Serialisation integrator
77% of Pharma Manufacturers are likely to